🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Did you miss yesterday's Tuesday Talk featuring Beta Bionics Founder and Executive Chairman Ed Damiano? If so, good news! A recording is now available. Register below to watch. linkedin.com/events/afather…

We are thrilled to announce the successful closure of our Series D funding round securing $100 million in new equity capital. newswire.com/news/beta-bion…

We are proud to be included in TIME's Best Inventions of 2023 list! #TIMEBestInventions

Did you hear the news? Express Scripts Pharmacy Benefit Services has added the iLet Bionic Pancreas and associated monthly supplies to their commercial national formulary offerings. betabionics.com/beta-bionics-a…

This morning, we announced the nationwide launch of the iLet Bionic Pancreas with Dexcom G7 System planned for December 18, 2023. Learn more: betabionics.com/ilet-bionic-pa…

The iLet Bionic Pancreas is now available nationwide with the Dexcom G7 CGM System. No new hardware is needed, and the iLet is compatible with all versions of Dexcom G7. Learn more: betabionics.com

We're proud to be featured on Fierce Medtech's latest Fierce 15 list, an annual report that recognizes the most innovative private medtech companies in the industry. fiercebiotech.com/special-report…

We’re excited to announce that we’re partnering with Xeris Pharmaceuticals on the development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump. newswire.com/news/xeris-ent…

We’re excited to announce that we’re partnering with Abbott and FreeStyle Libre to integrate the FreeStyle Libre 3 Plus sensor with the iLet Bionic Pancreas. Learn more: betabionics.com/beta-bionics-a…

Exciting news! iLet users can now invite friends and family to join their #BionicCircle to see their diabetes data and receive alerts. Learn how: betabionics.com/resources/bion…

Great news for Android users! 🎉 The Beta Bionic Circle app is now live, letting loved ones easily stay connected to your diabetes management. Download now and join the circle! #GoBionic Learn how at: bit.ly/bionic_circle

Announcing a game-changing integration with Abbott and @FreeStyleDiabetes FreeStyle Libre 3 Plus sensor with our iLet Bionic Pancreas! 🎉 Discover if the iLet Bionic Pancreas is right for you by visiting the link in our bio. *User must be carb aware. Safety Link in bio

Welcoming Beta Bionics to the Nasdaq Exchange Opening Bell. x.com/i/broadcasts/1…

Congrats to Beta Bionics on their IPO today. My 13-year-old son was diagnosed with #T1D 3 1/2 years ago. Insulin pumps with CGM integration and automated insulin delivery change lives. The T1D community applauds each technology advancement on the road to a cure. $BBNX

🫶 Making diabetes easier for everyone, every day . 🤖 Beta Bionics is a medical technology company dedicated to simplifying and improving the treatment of diabetes. 🔔 Thrilled to ring in your Nasdaq Exchange listing, $BBNX!

Today is a significant day in Beta Bionic's history as we formally go public. Our message is lighting up Times Square today, and this milestone truly represents the dreams and hard work that led to this accomplishment. ⁠ $BBNX

.Beta Bionics $BBNX makes its IPO today, and CEO Sean Saint joined Oliver Renick to give an overview of the company. "The iLet Bionic Pancreas: the next generation of insulin pumps" ⬇️

🗻 From a child’s diabetes diagnosis to becoming #NasdaqListed: what a journey for Beta Bionics! 🤝 Proud to be your exchange partner as you continue to make diabetes easier for everyone, every day.

⚡ 80% of people with diabetes live with uncontrolled blood glucose and are at risk from complications. Beta Bionics is working to change that. 🎉 We’re so excited $BBNX is now #NasdaqListed! Catch the recap of their big day. ⬇️

“Diabetes doesn’t limit you in anyway. You can do absolutely anything with it.” 💪 The mission of Beta Bionics is simple, they’re a company dedicated to simplifying and improving the treatment of diabetes. CEO Sean Saint shares the company story, his entrepreneurial journey,